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Abstract
Damage caused by administering general anesthetics to the developing brain in young
children and pregnant mothers is of concern among practicing anesthesia providers.
Studies using young rodents and non-human primates have shown that animals are
susceptible to neurodegeneration when exposed to high concentrations of general
anesthesia. Randomized control trials using rodents as subjects used behavioral and
histological experiments to determine the adverse effects of general anesthetics including
the inhalation agents desflurane, isoflurane, and sevoflurane in addition to intravenous
ketamine. The purpose of this systematic review was to examine the current literature to
determine the effects these anesthetics pose on rodent subjects and how that translates
into the human population. This systematic review was constructed using both PRISMA
and ARRIVE as guidelines. A literature review was conducted and data was collected
from each study. A cross-study analysis was created through data collected from each
study by the author of this systematic review. The randomized control trials reviewed
provide evidence that the types of inhalation and intravenous anesthesia agents studied
can affect the developing brains of rodents. Anesthesia providers can use these results as
a guide when administering anesthesia to infants, young children, and gravid mothers,
however, more studies focusing on the long-term effects these agents have on children
are warranted.
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THE EFFECT OF ANESTHESIA ON THE DEVELOPING BRAIN
Background/Statement of the Problem
Potential damage caused by administering general anesthetics to the developing
brain in young children and pregnant mothers is of grave concern among practicing
anesthesia providers. Anesthetic agents and drugs could adversely affect the brain of
children as it develops by possibly disrupting normal neuroapoptosis (Aker, Block &
Biddle, 2015). Neuroapoptosis is the body's normal controlled cell death that is crucial in
the role of brain development (Aker et al., 2015). Controlled cell death plays a vital role
in neurodevelopment and helps to limit redundancy, faulty neurons, or unused neurons
from crowding the developing brain (Creely, 2016).
Anesthesia can disrupt this normal development by altering neuroapoptosis and
increasing neurodegeneration, causing unwanted damage (Reddy, 2012). Studies using
young rodents and non-human primates have shown that animals are susceptible to
neurodegeneration when exposed to high concentrations of general anesthesia. This
damage could cause learning delays, long term memory deficits, and spatial recognition
impairment in the human population as well (Reddy, 2012). Additionally, studies that
have examined infants and children exposed to large quantities of anesthetics have
demonstrated increased difficulties in learning as well as more behavioral problems when
compared to that of the general population of the same age (Reddy, 2012). There is
currently, however, no available empirical evidence that describes how exposure to
anesthesia in children under age four may lead to adverse effects on neurological
development. Most of the current human research regarding anesthetic effects on the
developing brain rely on retrospective studies, and existing databases, to review the long-
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term effects of anesthesia. Currently, studies such as the SMART Tots initiative are
underway to explore how anesthesia affects human children and fetuses (Aker et al.,
2015). Although there are significant expenses and ethical dilemmas to consider in the
design of large-scale research in this topic area, future evidence from large randomized
control trials (RCTs) such as the SMART Tots study will hopefully paint a clearer picture
on how anesthesia affects human subjects as the brain develops (Aker et al., 2015).
As more and more gravid mothers and young children are undergoing general
anesthesia for procedures, it is becoming vital to determine how anesthesia affects the
developing brain. Studies that focus on inhalation agents, intravenous agents, and ways to
protect the young brain are becoming more crucial. Knowledge generated from sound
research is needed to determine the safest and most effective way to administer
anesthesia to this vulnerable population.
The purpose of this systematic review was to determine the effects of general
anesthesia on the developing brain of fetuses and children age four and under. This
systematic review comprehensively reviewed literature that focus on how anesthetics
affect the developing brain.
Next, a review of the literature will be presented.
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Literature Review
Potential damage caused by administering general anesthetics to the developing
brain in young children and pregnant mothers is a hot topic among practicing anesthesia
providers. This damage could cause learning delays, long term memory deficits, and
spatial recognition impairment (Aker et al., 2015). In utero, the developing brain usually
undergoes neuroapoptosis, defined as normal controlled cell death vital to brain
development (Aker et al., 2015).
A literature search was completed using the keywords: "Brain development,"
"Anesthesia Effect on the Developing Brain," "Neuroapoptosis," and "Effects of Volatile
Anesthetics." CINAHL and PubMed were used to locate relevant literature for
evaluation. The literature search was limited to retrospective studies, random controlled
trials (RCT), and systematic reviews no older than the year 2011.
Fetal Brain Development
Of all the human organ systems, the brain is the most complex. It is made up of
over 100 billion information processing cells known as neurons (Stiles & Jernigan, 2010).
Neurons become created through the process of neurogenesis. These cells make up large
networks that are responsible for thoughts, feelings, actions, and sensations (Stiles &
Jernigan). Early in fetal development, brain tissue derives from the ectoderm, which
begins as a neural plate on day 16 of gestation; by day 21 this tissue forms a neural tube
(Chudler, 2015). The neural tube splits into three separate areas, including the forebrain,
midbrain, and hindbrain. In the 7th week of development, the brain divides again through
a process called encephalization, which increases the size and functionality of the brain.
The majority of the brain development occurs during the prenatal period where the brain
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will increase by 260% during the third trimester (Rothbaum et al., 2015). Between the
last trimester and age three, the human brain sustains rapid development. Neurogenesis
will continue after birth in the postnatal period, but to a much lesser degree (Stiles &
Jernigan, 2010). Around 250,000 neurons are added every minute and become connected
via synapses, a process known as synaptogenesis. By adult age, there are an estimated 60
trillion neuronal connections (Stiles & Jernigan, 2010).
The physiologic processes of synaptogenesis, neurogenesis, and gliogenesis allow
the neurons to mature and differentiate. Synaptogenesis depends on constant neuronal
signaling, communication, and feedback processing to create meaningful neuronal
connections. During these developments, an overproduction of neurons, synapses, glial
cells, and neural processes occurs (Stiles & Jernigan 2010). Neurons that are redundant or
serve no purpose get pruned via neuroapoptosis.
In order for these physiologic processes of brain development to occur, proper
nutrition of the mother is warranted. Adequate intake of vitamins and minerals help
promote adequate brain development. For example, iron plays a part in neuronal
myelination and development of the frontal lobe in infants (Young, 2012). Another prime
example is the intake of vitamin B12, which plays an essential role in neurologic and
sensory developments (Rothbaum, Aly, & Massaro 2015). Without a balanced diet, a
malnourished mother may produce children with smaller head circumference and lower
brain weight which can contribute to an adverse neurodevelopmental outcome
(Rothbaum et al., 2015).
The brain is also susceptible to outside environmental factors that can cause
adverse outcomes during development. A mother exposed to such things as lead,
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mercury, and radiation exposure can result in reduced cognitive and motor skills in the
child (Rothbaum et al., 2015). Lead, in particular, is known to injure developing neurons
(Rothbaum et al., 2015). Drugs such as nicotine, alcohol, and cocaine ingested by the
mother can be neurotoxic to the developing fetus resulting in lower intelligent quotient,
developmental delays, and growth delays (Rothbaum et al., 2015).
Excessive alcohol intake by the mother can lead to fetal alcohol syndrome in the
infant, resulting in many disorders causing intellectual and behavioral impairments.
These disorders are known as fetal alcohol spectrum disorders characterized by a wide
range of teratogenic and psychological defects that can result in non-hereditary mental
delays depending upon the amount of alcohol consumption (Parker et al., 2014). Even a
small amount of alcohol ingestion during pregnancy is known to contribute to cognitive
and behavioral issues. These issues include mood disorders, aggression and addictive
behavior by negatively affecting neuronal and central nervous system development in
utero (Parker et al., 2014).
Animal studies are employed to ethically explore the effects of alcohol. For
instance, Brocardo et al. (2017) studied Sprague Dawley rats exposed to ethanol during
critical periods of brain development. The pregnant female rats separated into three
cohorts represent their respective different trimesters. First-trimester pregnant rats
(ETOH-1) were given a liquid diet in the first trimester which included 35.5% of their
calories obtained from ethanol (Brocardo et al., 2017). Following the first trimester
equivalent time, the ETOH-1 group ate a regular chow diet. Similarly, the second
(ETOH-2) and third (ETOH-3) trimester rat groups received liquid foods containing
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alcohol in their respective trimester, and chow for the other trimesters. Blood alcohol
levels were also monitored throughout the pregnancy (Brocardo et al., 2017).
The rat pups were sacrificed to examine the effects the ethanol had on brain
tissue. It was found that oxidative damage was caused to the hippocampus of the ethanolexposed rat pups which contributes to developmental delays (Brocardo et al., 2017).
There was also a decrease in the endogenous antioxidant glutathione levels in the
hippocampus and cerebellum when exposed to EtOH. A two-way analysis of variance
(ANOVA) revealed the effects of a developmental condition and period of exposure to
alcohol as a significant interaction (F(2,70) =9.56, p < 0.01) (Broccardo et al., 2017).
Analysis revealed total glutathione levels were significantly reduced in the ETOH-1
group when compared to their controls (p < 0.01) within the hippocampus regions of CA
and PFC (Brocardo et al., 2017). Glutathione reduction is known to affect synaptic
plasticity (Brocardo et al., 2017). Synaptic plasticity is the ability for synapses to weaken
or strengthen and are vital to memory formation (Brocardo et al., 2017). The results of
this study indicate that there is no safe time in pregnancy to ingest alcohol, and by doing
so can cause long-term alterations in brain function associated with fetal alcohol
spectrum disorders (Brocardo, et al., 2017).
The brain of the fetus is noted to be very fragile as it develops. It is susceptible to
many outside influences and requires well-balanced nutrition by the mother. When
exposed to teratogens such as drugs, environmental agents, and alcohol, neurotoxicity to
the brain can occur leading to abnormal neuronal development and later cognitive delays.
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Neurotoxicity
Neurotoxicity is a biological or chemical agent causing toxicity to the peripheral
or central nervous system. It defines any adverse effect on the chemistry structure or
function of the nervous system, during development or at maturity, induced by chemical
or physical influences (Giordano & Costa, 2012). It is also categorized by reversible and
irreversible brain damage, which could lead to neurocognitive deficits (Vilsides & Xie,
2012). Neurotoxicity can cause changes in neurons (neuronopathy), axon degeneration,
and the loss of glial cells around the axon (myelinopathy) (Giordano & Costa, 2012).
There are over 200 well-established chemicals that are neurotoxic to humans, including
mercury, lead, and organophosphates, that can be neurotoxic to the fetus in utero
(Giordano & Costa, 2012). Exposure to these chemicals prenatally and early postnatally
possesses damaging influences on the structure of the nervous system (Giordano &
Costa, 2012). These influences can lead to cognitive disabilities including learning
disabilities and developmental delays.
Neurotoxicity related to Anesthesia. Anesthesia is known to cause neurotoxicity
in some populations, particularly children and the elderly (Vilsides & Xie, 2012).
Inhalation and intravenous anesthetics have been shown to cause neuroapoptosis, caspase
activation, b-amyloid protein accumulation, and neurodegeneration in animals that can
lead to cognitive defects (Vilsides & Xie, 2012). Drugs used in anesthesia can adversely
affect neurotransmitters and receptors that are vital to brain development. This neurotoxic
insult can disrupt brain development contributing to cognitive and behavior issues later in
children exposed to anesthesia (Creeley, 2016). The importance of these receptors will be
explored further in the discussion of neuroapoptosis.
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Neuroapoptosis
Apoptosis is a physiological process that targets cells to be phagocytized by
macrophages in what is known as programmed cell death (Aker, Block, & Biddle, 2015).
The mechanism of apoptosis can be categorized into four distinct phases: signaling,
control and regulation, execution, and removal of the dead cell (Bennetts & Pierce,
2010). The first phase, signaling, begins through a stimulus caused by tumor necrosis
factor that triggers the apoptotic pathway, starting programmed cell death. The second
control, and regulation, phase determines whether to commit or abort, apoptosis. If
committed during this step there is no turning back. During the third stage of execution,
the cell begins to break apart by proteolytic caspases. In the final stage, the cell is
removed through phagocytosis by macrophages (Bennetts & Pierce, 2010).
Neuroapoptosis is programmed cell death that is used to help control neuronal
development. During neuroapoptosis, 50-70% of the excess neurons and synapses
produced become phagocytized. The brain contains receptors, such as N-methyl-Daspartate (NMDA) and g-aminobutyric acid (GABAA) that are vital to normal neuronal
development (Aker, Block, & Biddle, 2015). N-methyl-D-aspartate, an excitatory
neurotransmitter, plays a significant role in learning and memory formation. During early
brain development, the major inhibitory neurotransmitter GABA is also excitatory. This
neurotransmitter is vital for neurogenesis and neuronal proliferation (Wu & Sun, 2015).
During this critical time of development, the brain's receptors are susceptible to outside
influences. Drugs, alcohol, and medications, such as those used in modern anesthesia, can
disrupt the programmed cell death of neuroapoptosis. If the errant neurons are not pruned
adequately via neuroapoptosis, long-term cognitive disability and brain malformation
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could occur causing a lifetime of intellectual disability that includes both cognitive and
behavioral effects (Creeley, 2016).
Wilder et al. (2009) conducted a retrospective study to examine the long-term
effects of anesthesia on children and learning disabilities. The authors hypothesized that
similar to how alcohol exposure can cause changes in the developing brain, anesthesia
may also contribute to adverse changes. The study included 5,357 children; of which 593
of the children exposed to anesthesia before age four. Investigators found that for those
who had a single exposure to anesthesia (n=449) it did not increase their chance of
developing a learning disability (adjusted hazard ratio 1.00; 95% CI, 0.79 –1.27).
However, those (n=144) that were exposed to two anesthetics (adjusted hazard ratio 1.59;
95% CI, 1.06-2.37) or to three or more anesthetics (adjusted hazard ratio 2.60; 95% CI,
1.60-4.24) significantly increased their risk factor (p < 0.001) for developing a learning
disability. These risk factors include deficiencies in reading, writing, and mathematics
(Wilder et al., 2009). Additionally, the estimated risk increased from 20% to 35% for
development of a learning disability by age 19 in those children exposed to multiple
doses of anesthesia versus children without anesthesia exposure (Wilder et al., 2009).
The authors concluded that multiple exposures to general anesthesia could lead to
learning disabilities caused by impairment of neural development.
Anesthesia: Overview
Anesthesia is defined as insensitivity to pain, especially as artificially induced by
the administration of gases or the injection of intravenous drugs before surgical
operations (Butterworth, Mackey, & Wasnick, 2014). The term anesthesia was first used
by the Greek philosopher Dioscorides to describe narcotic-like effects caused by the plant

10

mandragora (Butterworth, Mackey, & Wasnick, 2014). Later the term was used by Oliver
Wendell Holmes to include a state of amnesia, analgesia, and narcosis to make pain free
surgery possible (Butterworth et al., 2014). There are several types of anesthetics
including inhalation anesthetics and intravenous anesthetics that combine to make up
general anesthesia. General anesthesia uses a combination of drugs to produce a loss of
consciousness. The combination of drugs causes muscle relaxation, analgesia, and
amnesia to safely and effectively allow patients to withstand surgical procedures.
Inhalation agents. Inhalation anesthesia was the first type of anesthesia used for
surgery in the 1800s before the invention of the hypodermic needle. WTG Morton
demonstrated the use of diethyl ether as the first general anesthetic in 1846 (Butterworth
et al., 2014). Diethyl ether is the precursor to modern volatile inhalation anesthetics such
as nitrous oxide, sevoflurane, desflurane, and isoflurane. These current gases are liquid at
room temperature, allowing them to transport easily and are relatively cheap to
manufacture. With the help of a vaporizer, these liquids evaporate quickly, making them
ideal as an anesthetic gas. All of the volatile inhalation agents act on inhibitory
neurotransmitters known as GABAA receptors in the brain (Garcia, Kolesky, & Jenkins,
2010). Nitrous oxide sometimes referred to as "laughing gas," is a non-volatile anesthetic
gas stored and administered from a gas cylinder. Nitrous oxide differentiates itself from
other inhalation anesthetics in that it acts on NMDA receptors (Garcia et al., 2010).
Intravenous agents. As the science of anesthesia has progressed, innovative
types of administration developed as well. The use of intravenous medications was first
introduced as a type of anesthetic in 1872 using the sedative Chloral Hydrate by Pierre
Ore' (Butterworth et al., 2014). Drugs such as morphine, barbiturates, and
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sedative/hypnotics are used today in many surgeries requiring anesthesia. These drugs
can be used in combination with inhalation agents, or on their own as part of general
anesthesia.
One of the most common hypnotic intravenous anesthetic drugs is propofol.
Propofol, when used for sedation, contains some amnestic properties. Its main effect is on
that of GABAA, a vital neurotransmitter to neurodevelopment, on the brain. GABAA is the
principal inhibitory neurotransmitter in the brain that propofol interacts with causing
disassociation resulting in unconsciousness and retrograde amnesia (Shafer, Rathmell, &
Flood, 2015). Intravenous anesthesia medications such as propofol have been found to
adversely affect the developing brain in animals (Andropoulos, 2017). Some evidence
suggests that specific intravenous anesthetic exposure in the developing fetus, and
children, may alter the GABA receptors placing them at risk for neurodegenerative
changes (Andropoulos, 2017).
There are additionally, adjunct intravenous medications used during general
anesthesia including benzodiazepines such as, midazolam, diazepam, and lorazepam
which have sedative effects that target GABA receptors (Garcia et al., 2010). Another of
the commonly used intravenous anesthetics, Ketamine, alters the NMDA memory
receptors which contribute to its anesthetic effects.
One of the earliest studies focusing on the blockade of the NMDA receptor was
completed by Ikonimidou (1999). The purpose of this study was to determine if the
blocking of NMDA receptors in parturient mothers, when exposed to certain anesthetic
agents, affected the neuronal development of the fetus or neonate. Ikonimidou (1999)
studied seven-day-old rat pups exposed to phencyclidine (PCP), carboxy pierazin-4-yl-
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propyl-2-phosphoric acid (CPP), and Ketamine. The rat pups were exposed to a steady
state of each of these drugs over 8 hours (Ikonimidou, 1999). After sacrificing the rats,
the authors used electron microscopy of the tissues to find that the exposure caused cell
degeneration in the rats by altering neuroapoptosis (Ikonimidou, 1999). These findings
suggest that fetuses and infants exposed to Ketamine and Nitrous Oxide during anesthesia
could be at risk for neurodegeneration of the developing brain.
In summary, the concern that neurotoxicity of general anesthesia to the
developing brains of infants and fetuses continues to be a pressing issue among providers.
Evidence through animal trials and retrospective studies shows a potential detriment to
this vulnerable patient population. As the surgical interventions on this population
increase the number of research increases.
Next, the discussion of the theoretical framework.
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Theoretical Framework
Nursing is a profession that uses many different theoretical approaches to guide
nursing practice. One such theorist, Betty Neuman, is known for The Neuman Systems
Model of Nursing. While working on her education, she developed her model while
lecturing at UCLA. "A Model for Teaching the Total Person Approach to Patient
Problems" was first published in 1972 and would soon develop into "The Neuman
Systems Model" used by nursing programs around the world (McEwen & Wills, 2014).
In Neuman’s System, humans are described as a composite of interacting
variables; physiological, psychological, sociocultural, developmental, and spiritual. These
variables promote homeostasis. Neuman's version of homeostasis describes a structure of
concentric rings, which represent three environments; internal, external, and created, all
of which may help a person adapt to stressors (McEwen & Wills 2014, p. 152). Neuman
describes the stressors as intra, inter, and extra personal in nature. Intrapersonal stressors
happen internally, for example, infection, thoughts, and feelings. Interpersonal stressors
occur from an individual's interaction with surrounding people. Extra personal stressors
arise outside of the individual and include such examples as finances and jobs. Lines of
defense are set up around an underlying structure or central core of a person to protect
from these stressors. These basic structures, which are common to all organisms, are
normal temperature range, genetic structure, response pattern, organ strength or
weakness, and ego structure (McEwen & Wills 2014, p. 152).
Neuman terms the first line of defense as the Flexible Line of Defense. This outer
line of the defense protects the human being from stressors. The second line of defense is
the Normal Line of Defense which adapts over time to keep the person in reasonable
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health. The final line of defense or Lines of Resistance, such as a person's immune
system, stabilizes the person back into wellness (Neuman & Fawcett, 2009). These
defenses protect a person from environmental factors and stressors, in turn, maintaining
wellness using a method of constant adaptation.
Another concept Neuman includes in the theory is prevention: primary,
secondary, and tertiary prevention. Primary prevention is the use of knowledge to reduce
the effects of environmental factors before causing a reaction. Secondary prevention
studies symptoms following exposure to stressors and uses interventions to decrease the
possible effects while tertiary prevention uses an adjustive process and maintenance
factors to return the person to a state of primary prevention.
The Neuman Systems Model can apply to how anesthesia affects the developing
brain. During procedures requiring anesthesia, the lines of defense are penetrated causing
detriment to the developing brain. This environmental factor creates an extra personal
stressor the body was not prepared to undergo. Once in the system, the anesthesia
becomes an intrapersonal stressor, which could cause neurotoxicity leading to cognitive
impairment. If cognitive impairment occurs from this invasion, other stressors can
develop.
Neuman's primary prevention concept is the best defense against adverse effects
of anesthesia on the developing brain. Primary prevention is used to reduce risk factors
for patients before the start of treatments. With increased knowledge of how anesthesia
contributes to cognitive impairment, research and trials can determine which modalities
of anesthesia cause the least amount of damage. Once established the treatment plan can
be used in vulnerable populations protecting the brain from impairment before it occurs.
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Even though Neuman's Systems model isn't very parsimonious, it can be shaped
to a variety of nursing situations whether it is how extra personal stressors wreak havoc
on a patient's diabetes or how anesthesia affects the developing brain the model can
determine how to reduce these stressors maintaining wellness in an individual.
Next, the Methods will be discussed
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Method
Purpose
The purpose of this systematic review was to determine the potential adverse
effects of anesthesia on the developing brain in an unborn human fetus and infant. This
review considers the following question: In children and fetuses of mothers undergoing
general anesthesia, what are the adverse effects of the perioperative medications on the
developing brain?
Search Strategy
The literature search was conducted using the CINAHL and PubMed online
databases simultaneously. The search term used was "effects of anesthesia," which
yielded over 100,000 hits. By using the terms "effects of anesthesia on the developing
brain" in the search engine results narrowed to 243 articles. The level of evidence and
pertinence determined the number of articles used, based on inclusion and exclusion
criteria listed below. Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) was developed and finalized in 2009 as a critical appraisal tool to
help authors develop systematic reviews (Moher, 2009). This critical appraisal tool
includes a checklist 27-item checklist and a four-phase flow diagram utilized to minimize
bias, provide reliable findings, and allow accurate conclusions to be drawn from the
collection of studies reviewed. Examples of the original checklist and flow diagrams can
be found in Appendix A. Articles meeting the criteria were evaluated using the PRISMA
flow diagram located in the results section for inclusion eligibility.
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Inclusion Criteria
The literature search articles will be evaluated by relevance according to the
purpose, intervention, and outcomes (PIO) design. The inclusion criteria will focus on
studies containing randomized clinical control trials conducted within the last ten years.
The clinical control trials will focus on the effects of anesthesia administered to young
rats and mice to evaluate the impact on the developing brains of the human population.
Exclusion Criteria
Exclusion criteria consisted of non-English written articles and articles older than
ten years. Subjective non-scientific articles were also dismissed.
Data Collection
The articles reviewed determined useful and relevant data. Data collected
included results from randomized control trials using primarily animal models such as
rodents. The effects of anesthesia on rodent models were classified and organized using
two tables. The second table consists of data collection, results, limitations and
conclusions.
Table 1
Data Collection Tool 1
Purpose

Study Design

Subject Demographics

Methods

Measurement
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Table 2
Data Collection Tool 2
Data Analysis

Results

Limitations

Conclusions

Outcomes specific to the effect on cognitive development after anesthesia was the
primary data collected. The articles focused on how intravenous and volatile gas
anesthetics affect the brain as the child develops in and out of the womb. The articles
explored cognitive defects such as memory and spatial reasoning by studying animals,
particularly rodents, using random control trials and real-time studies on rat pups exposed
to the anesthesia agents. The information gathered from these articles was used to form
results indicating the best type of anesthesia to use for fetuses and young children, and
what can be done to avoid any adverse effects of anesthesia during surgery.
Data Synthesis and Cross Study Analysis
The data collection tools created were used to gather information from the
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randomized control trials examined in this systematic review. A cross study analysis was
then performed through creation of a comparison table that evaluated the studies by
Behavioral Analysis Results, Histological Study Results, and Neurodegeneration Results.
Data was then depicted in the table below (Table 3) with results described later in this
systematic review (Appendix E).

Table 3
Author/Year/Anesthetic

Behavioral Analysis
Results

Histological Study
Results

Neurodegeneration Results

Critical Appraisal
The Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines
for Randomized Control Trials, which is specific to animal studies was used to verify the
relevance, integrity, and results of the articles utilized in this review. Each article was
reviewed individually using the ARRIVE questionnaire checklist specific to animal
research studies. The ARRIVE guidelines consist of a checklist of 20 items describing the
minimum information that all scientific publications reporting research using animals
should include (Kilkenny et al., 2010). Table 4, included below shows the ARRIVE
grading system used to evaluate the studies reviewed.
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Table 4
Arrive Grading System
Recommendation

Item #
Title

1

Provide as accurate and concise a description of the content of the article as
possible.

0= inaccurate
1= accurate

Abstract

2

Provide an accurate summary of the background, research objectives, including
details of the species or strain of animal used, key methods, principal findings and
conclusions of the study.

0= inaccurate
1= accurate

Background

3

Objectives

4

a. Include sufficient scientific background
to understand the motivation and context for the study and explain the
experimental approach and rationale.
b. Explain how and why the animal species and model being used can address
the scientific objectives and, where appropriate, the study’s relevance to
human biology.
Clearly describe the primary and any secondary objectives of the study, or
specific hypotheses being tested.

0= sufficient
1= insufficient

0= Clear
1= Not Clear

Methods
Ethical

5

statement

Indicate the nature of the ethical review permissions, relevant licences and
national or institutional guidelines for the care and use of animals, that cover the
research.

0= Clear
1= Not Clear

Study design

6

Experimental

7

For each experiment and each experimental group, including controls, provide
precise details of all procedures carried out.

0= Clear
1= Not Clear

8

Provide details of the animals used, including species, strain, sex, developmental
stage, and weight.

0= Clear
1= Not Clear

9

Housing: type

0= Clear
1= Not Clear

For each experiment, give brief details of the study design including:
-The number of experimental and control groups.
-Any steps taken to minimise the effects of subjective bias when allocating
animals to treatment (e.g. randomisation procedure) and when assessing results
(e.g. if done, describe who was blinded and when).

0= Clear
1= Not Clear

-The experimental unit (e.g. a single animal, group or cage of animals).
Procedures
Experimental
Animals
Housing and
Husbandry

Husbandry: breeding, light/dark cycles, temperature, etc.

Sample size

10

Number of animals used in each experiment.

0= Clear
1= Not Clear

Animal Group

11

-Give full details of how animals were allocated to experimental groups,
including randomisation or matching if done.
-Describe the order in which the animals in the different experimental
groups were treated and assessed.
Clearly define the primary and secondary experimental outcomes assessed (e.g.
cell death, molecular markers, behavioral changes).

0= Clear
1= Not Clear

Allocations
Experimental
outcomes

12

0= Clear
1= Not Clear
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Statistical

13

methods

-Provide details of the statistical methods used for each analysis.
-Specify the unit of analysis for each dataset (e.g. single animal, group of
animals, single neuron).
-Describe any methods used to assess whether the data met the assumptions
of the statistical approach.
For each experimental group, report relevant characteristics and health status of
animals (e.g. weight, microbiological status, and drug or test naïve) prior to
treatment or testing. (This information can often be tabulated).

0= Clear
1= Not Clear

Baseline data

14

Numbers

15

-Report the number of animals in each group included in each analysis.
Report absolute numbers (e.g. 10/20, not 50% 2).
-If any animals or data were not included in the analysis, explain why.

0= Clear
1= Not Clear
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Report the results for each analysis carried out, with a measure of precision
(confidence interval).

0= Clear
1= Not Clear
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-Give details of important adverse events in each experimental group.

0= Clear
1= Not Clear

analyzed
Outcomes &
estimation
Adverse events

0= Clear
1= Not Clear

-Describe any modifications to the experimental protocols made to reduce
adverse events.
Interpretation/

18

scientific
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-Describe any implications of your experimental methods or findings for the
replacement, refinement or reduction (the 3Rs) of the use of animals in research.
Comment on whether, and how, the findings of this study are likely to translate
to other species or systems, including any relevance to human biology.

0= Clear
1= Not Clear
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List all funding sources (including grant number) and the role of the funder(s) in
the study.

0= Clear
1= Not Clear

translation
Funding

0= Clear
1= Not Clear

-Comment on the study limitations including any potential sources of bias, any
limitations of the animal model, and the imprecision associated with the results.

implications
Generalizability/

-Interpret the results, taking into account, the study objectives and
hypotheses, current theory and other relevant studies in the literature.

Next is a discussion of the Results
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Results
Prism Flow Diagram

n = 140)

Records after duplications
removed: (n= 235)

Records screened by
Title/Abstract: (n= 235 )

Full-text articles assessed
for eligibility: (n= 21)

Records excluded:
(n= 214 )

Full-text articles
excluded with reasons:
(n=17)

Studies included in
qualitative synthesis: (n=4 )

The PRISMA flowchart above, along with the inclusion and exclusion criteria
discussed in the methods section were used to narrow down, and ultimately determine
articles appropriate for the systematic review. A total of eight articles were determined to
be duplicated in both databases and were discarded. After reviewing the titles and
abstracts further elimination of articles occurred using the previously stated exclusion
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criteria. This ultimately brought the total number of articles to 21. The study articles were
further narrowed down to four in total by using both exclusion and inclusion criteria. The
exclusion criteria consisted of non-English written articles, articles older than ten years,
and subjective non-scientific articles, while the inclusion criteria encompassed
randomized control trials.
O’Farrell, Foley, Bugger, & Gallagher (2018) conducted a randomized control
trial using 15-day old Wistar rat pups to evaluate the neurotoxic effects of inhalation
agents. This experimental study exposed the rats to urethane, isoflurane and sevoflurane
(Note: Urethane was admitted as an outcome criteria in this systematic review, as it is not
currently being used as an anesthetic in humans). All animals were administered either
the anesthetic or a placebo (O’Farrell et al., 2018). The rats were then tested at 48 hours
and 96 hours for behavioral and histological analysis (Appendix B, table B-1).
O’Farrell et al. (2018) determined that in rats exposed to the volatile anesthetic
gases: sevoflurane and isoflurane, demonstrated enhanced excitability through a number
of behavioral parameters. The behavioral parameters observed included activity,
grooming, rearing, and suckling (O’Farrell et al., 2018). Activity and locomotion
included observation on how much each subject moved in an enclosed activity box. The
activity parameters were averaged based on the time the animal spent moving and the
percent of time active (O’Farrell et al., 2018). Grooming and rearing behavioral
parameters included comparisons of how much time the mother would groom and spend
time with the rat pup after anesthesia exposure versus a control group. The suckling score
was calculated by monitoring the time the rat pups spent feeding on their mother
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(O’Farrell et al., 2018). By observing these behaviors in the rat pups exposed to
sevoflurane and isoflurane, versus a control group, researchers could determine if any
insults to the brain occurred. The observations took place at 48 and 96 hours post
exposure.
Results related to animal behavior were reviewed at 48 and 96 hours (Appendix
C, Table C-1). At 48 hours post exposure there was little clinical difference found in the
activity parameter in the sevoflurane and isoflurane exposed animals, when compared to
the control. Scores of 11.7 +/- 2.7 were awarded for sevoflurane and 9.38 +/- 3.21 for
isoflurane versus the control score of 9.9 +/- 1.66 with a p value of 0.03. However, there
was a notable increase at 96 hours post exposure (O’Farrell et al., 2018). With
sevoflurane scoring 15.8 +/- 1.56 and Isoflurane scoring 15.4 +/- 2.03 versus the control
group at a score of 11.2 (p = 0.02) (O’Farrell et al., 2018). Suckling scores for the
sevoflurane group were significantly decreased at 48 hours 1.67 +/- 0.33 compared to the
control group of 3.20 +/- 0.53 (O’Farrell et al., 2018). At 96 hours Sevoflurane continued
to decrease to 0.89 +/- 0.26 versus the control groups score of 2.42 +/- 0.36 (O’Farrell et
al., 2018). Isoflurane exposed rats only saw a significant decrease in suckling scores of
1.13 +/- 0.23 at 96 hours when compared to the control group (O’Farrell et al., 2018).
Rearing scores for sevoflurane (1.67 +/- 0.33) exposed rats decreased compared to
controls (3.20 +/- 0.53), whereas the isoflurane group (2.63 +/- 0.37) demonstrated little
difference compared to the baseline control group (p = 0.04) (O’Farrell et al., 2018).
O’Farrell et al. (2018) also evaluated histological studies, such as total cell counts
located in the piriform cortex of the volatile anesthetic exposed rats (Appendix C, Table
C-1). By counting the number of dying cells in this cortex, O’Farrell et al. determined the
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amount of neurodegeneration that occurred in the brain tissue of the exposed rats. Again,
using the time of 48 hours post exposure and 96 hours post exposure, harvested brain
tissue was examined to count the total cells present in the layers of the piriform cortex.
Total cell counts were calculated in layer II of the piriform cortex for each of the
rats exposed to volatile anesthetics (O’Farrell et al., 2018). A mean +/- SEM value was
calculated for each exposed group (O’Farrell et al., 2018). At the 48-hour time point both
the isoflurane and sevoflurane group (p = 0.03) demonstrated an increase in total apoptic
cells in comparison to the control group. There was no significant change between the
sevoflurane group when compared to the control group at 96 hours (O’Farrell et al.,
2018). Isoflurane had a significant reduction in total cells in the brain at 96 hours post
exposure (p = 0.03) (O’Farrell et al., 2018). The results in this study demonstrated that
isoflurane damaged a larger amount of tissue leading to neurotoxicity, resulting in more
harm than sevoflurane to the developing brain.
Using the ARRIVE guidelines it was determined that O’Farrell et al. (2018)
lacked a clear ethical statement from the authors. Funding of the study also was not
disclosed. Furthermore, the paper also failed to divulge details on the how the rats were
housed during the experiments. Deficiencies in these categories resulted in a score of
zero.
Tao et al. (2016) aimed to determine if isoflurane or desflurane caused more harm
to the developing brain by creating a randomized control trial using three groups of 119
six-day-old mice: a control group, isoflurane group, and a desflurane group (Appendix B,
Table B-2). After being subjected to their respective anesthetic groups the mice were
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placed in two experiments in addition to brain harvesting to determine the effects of the
anesthetics, isoflurane and desflurane, on spatial reasoning and memory. The mice were
divided equally among the litters to minimize differences associated with different
mothers. Mice that had been exposed to these volatile gases were put through learning
and memory condition testing including the Morris water maze (MWM) and a fear
conditioning test (FCT) (Tao et al., 2016). Prior to volatile gas exposure the MWM trials
mice were placed in a small pool and investigators determined how fast it took them to
reach a hidden platform. Once they learned how to find the platform the mice were then
divided into a control group, isoflurane group, and desflurane exposed groups. After
exposed to their respective anesthesia, the mice would then take the MWM again (Tao et
al., 2016).
During the MWM test escape latency was measured over seven days. Escape
latency was determined by calculating how long it took the mice to cross platforms (Tao
et al., 2016). Each day they were put in the tank the mice would remember and learn what
to do and the times would improve. The data was gathered (Appendix C, Table C-2) and
it was determined that escape latency times of mice treated with isoflurane for 2 h daily
for 3 days were significantly higher than those recorded for mice that were treated only
with the control group of oxygen. A two-way ANOVA test with repeated measurements
found there was a significant effect on escape latency times with mice treated with
isoflurane at the P < 0.05 confidence level for the conditions versus mice in the oxygen
control group [F = 2.734, p = 0.0153] (Tao et al., 2016). However, there were no
significant differences in escape latency times (MWM test) with mice treated with
desflurane versus the control group [F = 0.3291, p = 0.9206] (Tao et al., 2016). The
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results determined that mice with multiple exposures to isoflurane versus multiple
exposures to desflurane contributed to causing long-term spatial learning and memory
impairment (Tao et al., 2016).
In the fear conditioning test (FCT) mice were placed in a chamber and allowed to
roam freely (Tao et al., 2016). After three minutes a tone would sound and a mild foot
shock would be administered to the mouse (Tao et al., 2016). Forty-eight hours after the
initial chamber exposure, and foot shock, the mice were placed in the chamber again.
During this period, referred to as a context test, the mice would be placed in the chamber,
and freezing times were recorded without a tone or shock (Tao et al., 2016). Freezing
times were the amount of time the mouse would stay still after the sound of the tone. This
was done to determine the ability of each mouse to contextually learn that placement in
this environment indicated an impending shock could be coming and the mice would
freeze. During the cue test, a tone would sound and no shock would be administered. The
cue or tone would signal that an impending shock was possible. Investigators recorded
the time for the mice to freeze with anticipation of an incoming shock. It was noted that
the isoflurane exposed mice froze less (30 seconds) during the context test, whereas
desflurane and control groups remained the same (50 seconds). These findings
(Appendix C, Table C-2) established that three exposures to isoflurane and not desflurane
decreased the freezing times during the contextual FCT (p = <0.01) (Tao et al., 2016).
However, there was no change noted in any group during the cue test, with all three
groups freezing for approximately 50 seconds (Tao et al., 2016).
Histological studies completed by Tao and colleagues (2016) examined the
hippocampus of the mice to determine the effects isoflurane and desflurane had on
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tissues. Tao et al. were specifically concerned with how the gases effected the
phosphorylation of Akt, a protein kinase, and glycogen, a synthase kinase 3B (GSK3B).
These kinases play a vital role in normal brain development and memory.
Phosphorylation can cause functional suppression of these kinases. By decreasing
phosphorylation learning and memory formation is affected.
Using western blot analysis, Tao et al. was able to examine the amount (%) of
phosphorylation that occurred in the hippocampus of the mice. During the analysis it was
determined that three exposures to isoflurane, but not desflurane, decreased the
expression of these kinases by 50% when compared to the control group (p < 0.01). This
demonstrates that multiple exposures to isoflurane affects learning and memory by
increasing neurotoxicity.
Tao et al. (2016) also investigated the use of lithium as a pretreatment for the mice
before isoflurane exposure to determine if it can reverse the effects on learning and memory
impairment. A two-way ANOVA test found that lithium administered 30 minutes before
isoflurane exposure effectively decreased escape latency times in mice treated with
isoflurane compared to a group just receiving saline as a control [F = 1.741, p = 0.0332]
(Tao et al., 2016). Tao et al. (2016) also evaluated whether lithium could reverse the
reduced levels of Akt, GSK3B, and Beta-actin. This experiment was conducted using three
groups; a control group, an isoflurane exposed group, and a lithium pretreated isoflurane
group. One-way ANOVA indicated that lithium pretreatment was able to reverse the
decrease in p-Akt (p < 0.05) and GSK3B (p < 0.01) phosphorylation suggesting that lithium
can reverse isoflurane neurotoxicity.
The evaluation of the Tao et al. (2016) study using the ARRIVE guidelines determined the
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study was deficient in certain categories. There was a lack of information on how the
animals were allocated to which group in the study. There was also a lack of translation
and what the results would mean in the human population when exposed to the anesthetics.
Tao et al. (2016) also failed to clearly define how their study was funded.
Wu, Wang, Guo, & Zhang (2018) investigated how the NMDA receptor
antagonist, ketamine, effects neuroapoptosis both by itself, and under hyperoxic
conditions (Appendix B, Table B-3). Investigators also examined the effect ketamine and
hyperoxia had on paO2 levels (Wu et al., 2018). The randomized control trial study used
7-day-old rat pups allocated into four groups: control, hyperoxia, ketamine, and ketamine
plus hyperoxia (Wu et al., 2018). The control group was injected with saline whereas the
ketamine included groups received subcutaneous injections of 50 mg/kg of ketamine. The
hyperoxic group and ketamine plus hyperoxic group were exposed to higher levels of
oxygen (60%) for 2 hours (Wu et al., 2018).
The NMDA glutamate receptor is a ligand-gated ion including an NR-1 subunit
that is vital to normal brain growth and development. Wu et al. (2018) aimed to
determine how much ketamine would affect neuroapoptosis (Appendix C, Table C-3).
Hyperoxic exposed rat pups (paO2 242.3 +/- 12.7 mmHg) and ketamine plus hyperoxic
exposed rat pups (paO2 244.7 +/- 9.1 mmHg) demonstrated an increase in paO2 levels
when compared to the control (paO2 89.8 +/- mmHg) (Wu et al., 2018). Pups exposed to
just hyperoxic conditions, exposure to 60% oxygen for two hours, demonstrated apoptic
scores similar to the control group (< 5 %). Pups exposed to ketamine without hyperoxia
were found to have increased apoptosis (30%) when compared to the control pups (p <
0.01) (Wu et al., 2018). While pups exposed to ketamine with hyperoxia showed more

30

apoptosis than pups receiving ketamine alone (55%) (p < 0.01) (Wu et al., 2018). The
results indicate that ketamine, with or without hyperoxia, can affect expression of the
NR-1 subunit which leads to an increase in neuronal apoptosis.
Using the ARRIVE guidelines to evaluate Wu et al. (2018) it was determined the
study was deficient in two categories. Translation of the results to the human population
when exposed to the anesthetics studied was not provided. Wu et al. (2018) also failed to
clearly define how their study was funded. Overall, the Wu et al. (2018) study scored
well in the majority of the ARRIVE guidelines created by Kilkenny et al. (2010).
The aim of the study conducted by Zheng, An, Cheng, & Wang (2013) was to
investigate whether different lengths of exposure time and different concentration
percentages of the volatile inhalation agent sevoflurane affected neuronal apoptosis in 21
seven-day-old neonatal Wistar rats (Appendix B, Table B-4). The rats were randomized
into five control groups. A control group, a group exposed to 1% sevoflurane for two
hours, a group exposed to 1% sevoflurane for four hours, a group exposed to 2%
sevoflurane for two hours, and a group exposed to 2% sevoflurane for four hours. Postanesthesia exposure subgroups were created that evaluated open-field tests and two
immunohistology tests. Behavior and learning were tested at weeks five, eight, and
fourteen after sevoflurane exposure.
Results related to apoptosis, behavior, and memory were tabulated (Appendix C,
Table C-4). Zheng et al. (2013) used an open field technique to determine excitability.
The rats were placed in a 41 cm x 41cm x 41 cm acrylic table and movements were
documented at 600 seconds (Zheng et al., 2013). At 8 weeks and 14 weeks the study
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group that had been exposed to 2% sevoflurane for four hours showed an increase in
movements and excitability compared to the control group (p < 0.05) (Zheng et al.,
2013). A Morris Water Maze trail like the one used by Tao et al. (2016) showed that
regardless of time duration or percentage of exposure, sevoflurane exposed rats showed
no significant impairment of memory, or learning, when compared to the control group
(Zheng et al., 2013).
Through Western Blot Analysis, Zheng et al. (2013) examined the cleavage of
PARP-1 cells in the hippocampus of the rats. The authors found that exposure to 2%
sevoflurane for four hours induces cleavage of PARP-1 in the hippocampus of exposed
rats (p < 0.05) versus the control group. Neonatal rat exposure to even the lowest
sevoflurane 1% concentration induced apoptosis (Zheng et al., 2013). Capase-3 proteases
along with PARP-1 play a central role in apoptosis. The more detected in the cells of the
brain the more neurodegeneration (Zheng et al., 2013). Animals treated with sevoflurane
exhibited dose and time dependent neurodegeneration. Capase-3 positive cells were
detected in multiple areas of the brain, with the most vulnerable area consisting of the
hippocampus (p < 0.05) (Zheng et al., 2013). These two immunohistology tests
indicated that sevoflurane exposure at different dosage and exposure times can increase
neuronal apoptosis in rats (Zheng et al., 2013).
Reviewing the Zheng et al. (2013) article using the ARRIVE guidelines created
by Kilkenny et al. (2010) found that the study was deficient in just two categories.
Similarly, to the Wu et al. (2018) study this study failed to provide how the results would
translate into the human population. The study also neglected to clearly define how the
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funding for the study was achieved. Overall, the Zheng et al. (2013) study scored well in
all the other ARRIVE guideline categories.
The four articles examined in this systematic review scored fairly well in all
categories within the ARRIVE guidelines with results tabulated in the table located in
Appendix D. All four articles scored a zero in the funding column (item 20) as no articles
gave clear definition on how their studies were funded. Zheng et al. (2013), Tao et al.
(2016), and Wu et al. (2018) did not provide clear evidence on how their results could be
translated into the human population resulting in a score of zero in that category (item
19). O’Farrell et al. (2018) lacked a clear ethical statement (item 5) and details on the
housing of the animals used for the experiment (item 9), resulting in a score of zero in
those categories. Tao et al. (2016) and O’Farrell et al. (2018) failed to divulge how they
chose to allocate the animals into specific study groups resulting in a score of zero for
that class (item 11). Otherwise, the articles remained proficient in the remaining ARRIVE
criteria created by Kilkenny et al. (2010).
The studies used for this systematic review were evaluated using Table 3 with
comparison results depicted in Appendix E. This table was used to cross analyze the
articles in the topics of behavioral analysis, histologic study results, and
neurodegeneration results.
Within behavioral analysis it was noted by O’Farrell et al. (2018) and Zheng et al.
(2013) that the anesthetics they studied, Sevoflurane and Ketamine respectfully, resulted
in an increase in excitability in their subjects. Tao et al. (2016) did not find any increase
in excitable activity in their subjects receiving isoflurane or desflurane; however, they did
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note issues with long-term memory impairment and learning dysfunction in those rodents
exposed to isoflurane. Wu et al. (2018) did not focus on behavioral parameters in their
study.
Histological analysis in all four studies uncovered an effect of anesthesia on
normal functioning cells in the brain. For example, O’Farrell et al. (2018) found that
during piriform cortical cell counts, there was a reduction in cells in those exposed to
isoflurane and sevoflurane. Tao et al. (2016) showed a decrease in phosphorylation of
Akt and GSK3B in Isoflurane exposed rats, but not in desflurane exposed rats. The Wu et
al. (2018) study determined a higher mRNA and NR-1 subunit expression in those
exposed to ketamine as well as ketamine + hyperoxia. Finally, Zheng et al. (2013)
determined that exposure to the inhalation agent sevoflurane increased cleavage of
PARP-1 in the hippocampus. Overall these studies demonstrate that based on histological
findings abnormal cellular changes in the brain related to anesthesia can lead to
neurodegeneration and effect neurological development.
Interestingly, the findings from O’Farrell et al. (2018) suggest that sevoflurane
induces less neurotoxicity than isoflurane. The number of apoptic cells during the counts
at 48 hours post exposure to sevoflurane were 1.75 micrometer versus 2.25 micrometers
in isoflurane. This result is indicative of isoflurane being more deleterious to the brain
than sevoflurane. Tao et al. (2016) similarly noted that isoflurane has more detrimental
outcomes than that of desflurane. Isoflurane was found to cause a reduction in
phosphorylation of the enzymes Akt and GSK3B, which are vital to signaling pathways
linked to brain and learning development. Wu et al. 2018 indicated that ketamine with,
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and without, hyperoxia exposure increased neuroapoptosis. Apoptic cells of ketamine
exposed rats increased by 35% in comparison to the control group. The Zheng et al.
(2013) study determined that exposure to sevoflurane in neonatal rats induced apoptic
neurodegeneration as a result of the cleavage of PARP-1 in the hippocampus.
Ultimately, the review of the cross-study analysis determined that all anesthetic
modalities reviewed in these four studies had some type of adverse effect. The effects
were indicated in either behavioral analysis, histologic analysis, or in some level of
neurodegeneration. These results determined that exposure to certain types of anesthesia
can adversely affect brain development in rodent subjects.
Next, is a discussion of the summary and conclusions.
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Summary and Conclusions
This systematic review intended to determine the effects of general anesthesia on
the developing brain of children and unborn fetuses. Anesthetic agents and drugs can
adversely affect the brain of children as it develops by disrupting normal neuroapoptosis.
(Aker et al., 2015). Due to ethical concerns, such as brain harvesting for histological
studies on the effects of anesthesia on the developing brain, randomized control trials
using humans as subjects were not found. This systematic review of four random control
trials provided evidence that the anesthetic agents studied: isoflurane, desflurane,
sevoflurane, and intravenous ketamine, in some form or another altered normal apoptosis
of rodents. As mentioned neuroapoptosis is the body's normal controlled cell death that is
crucial in the role of brain development (Aker et al., 2015). Controlled cell death plays a
vital role in neurodevelopment and helps to limit redundancy, faulty neurons, or unused
neurons from crowding the developing brain (Creely, 2016). The effect of the
neurodegeneration in these rodent studies led to the discovery of some adverse findings
in learning and memory impairment, which may be equate to similar findings in humans.
The CINHAL and Pubmed databases were utilized during this systematic review.
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses was used to
analyze, limit bias and draw accurate conclusions of the articles allocated during the
database search. Critical analysis and cross study analysis were completed using the
Animals in research: reporting in vivo experiments (ARRIVE) for Randomized Control
trials specific to animal studies. ARRIVE utilizes a checklist and grading scale to
determine articles searched meet the minimum requirements of scientific studies using
animals as subjects.

36

After reviewing the databases, four articles were chosen that focused on animal
models which could be used to determine the effects of general anesthesia on developing
brains. These studies demonstrated that volatile inhalation anesthetics, and some
intravenous administrated anesthetics, currently used in anesthesia practice is linked to
neurodegeneration and neurotoxicity in the developing brains of rodents.
O’Farrell et al. (2018) demonstrated that rats exposed to just one dose of the
inhalation agent isoflurane produced neurologic toxicity in their piriform cortex. Both
isoflurane and sevoflurane exposed rats were also found to suffer from increased activity
levels and decreased suckling times. Tao et al. (2016), was able to show that exposures to
isoflurane, but not desflurane, induced learning and memory impairment in mice. Tao et
al. (2016) point out that this may attributed to isoflurane’s effect on the Akt/GSK3ß
signaling pathway, leading to neurotoxicity in the developing brain. Notably, it was
further observed that lithium attenuated the effects of isoflurane, thus improving learning
and memory (Tao et al., 2016).
This is similar to the cognitive effects that environmental factors, such as alcohol
or lead exposure can have on brain development. While isoflurane effected memory and
learning impairment in rats, alcohol has been found to act comparably in exposed fetuses
(Parker et al, 2014). O’Farrell et al. (2018) noted that isoflurane exposed rats had a
decrease in suckling times, which results in improper feeding, inadequate nutrition and
poor development. Likewise, children and unborn fetuses who don’t have adequate intake
of vitamins and minerals are noted to have deficiencies in both neuronal myelination and
frontal lobe development (Rothbaum et al., 2015; Young, 2012). Without the proper
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nutrition from being able to feed, the anesthesia exposed rats suffer a similar
developmental disadvantage.
Wu et al. (2018) administered ketamine to seven-day-old rats under normal and
hyperoxic conditions and compared this to a control group, and a hyperoxia only group.
Wu et al. (2018) found that ketamine can cause abnormal neuroapoptosis in the
developing rat brain, and this was further exacerbated under hyperoxic conditions. This
was believed to be due to the effect of ketamine on NMDA receptor NR-1 expression
(Wu et al., 2018). These findings provide evidence regarding the safety of ketamine
administration alone, or under hyperoxic conditions, on the developing rat brain (Wu et
al., 2018). Likewise, Ikonomidou (1999) study of seven-day-old rat pups exposed to
ketamine for over 8 hours found neurological cellular degeneration and altered
neuroapoptosis. Ikonomidou (1999) findings along with the results of Wu et al. (2018)
indicates that the fetuses of parturient mothers, as well as infants, who receive ketamine
could be subjected to neurodegeneration. However, neither study conducted a behavioral
analysis on the exposed rats to determine if those traits could be translated into the human
population.
Zheng et al. (2013) examined the effects of sevoflurane, at different durations, on
neuronal apoptosis, development, and adaptability of exposed rats. Zheng et al. (2013)
found that higher dosages and longer duration of sevoflurane led to greater
neuroapoptosis in exposed rats. It was also found that exposure to sevoflurane caused an
increase in excitability, however, it was noted by Zheng et al. (2013) that spatial memory
and learning was not affected in the rats exposed to sevoflurane.
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The findings of Zheng et al. are in contrast to those of a retrospective study by
Wilder et al. (2009). Wilder et al. determined that children exposed to not one, but
multiple, doses of anesthetics were more likely to develop learning difficulties. Zheng et
al. (2013) noted that more frequent and longer duration of exposure to sevoflurane
affected excitability and neuroapoptosis, but not memory and learning. O’ Farrell et al.
(2018), however, did note memory and learning impairment with isoflurane. These
results indicate that it may not just be a dose and time dependent issue with anesthesia
exposure in children and infants, but the type of anesthetic agent as well.
Findings of the cross-study analysis in this systematic review revealed that two
studies (O’Farrell et al., 2018; Zheng et al., 2013) demonstrated an increase in
excitability in their subjects during behavioral analysis. Tao et al. (2016) noted issues
with long-term memory impairment and learning dysfunction in rodents exposed to
isoflurane. Similar changes in the brain leading to cognitive and behavior changes has
likewise been noted in children exposed to alcohol during pregnancy (Parker et al., 2014).
Comparably, environmental factors such as: mercury, radiation, or lead has also been
found to reduce cognitive ability and motor skills in children (Rothbaum et al., 2015).
Wu et al. (2018) did not focus on behavioral parameters during their study, which is
unfortunate because behavioral analysis information regarding the behavioral effects of
ketamine would be beneficial to anesthesia practice.
The histological findings synthesized in the cross-study analysis reveals that all
four studies, (O’ Farrell et al., 2018; Tao et al., 2016; Wu et al., 2018; Zheng et al.,
2013), uncovered an anesthesia effect on normal functioning cells in the brain. All

39

histological findings show abnormal changes in the brain can lead to neurodegeneration
and effect development of the brain. Due to ethical concerns cell study of the brain in
children is unable to be completed. This is a limitation when trying to translate the animal
study findings to that of the human population. Although the results of this review
indicate strong evidence that anesthetic agents result in neurotoxicity in neonatal rodents,
it is not possible to determine to what degree these results correlate to the developing
human brain. Rodents develop at a much faster rate than children and the brains of
humans are more complex when compared to rodents (Stiles & Jernigan, 2010).
In conclusion, this systematic review provides evidence that rodents, such as mice
and rats, exposed to various inhalation and intravenous anesthetic agents can have a
negative impact on their developing brain. These unfavorable outcomes can lead to
learning impairment and memory issues that could affect the rodents during their
lifetime. While these articles provide evidence regarding how anesthesia can affect the
developing brains of rodents, further study needs to focus on the developing brains of
humans. There are significant expenses and ethical dilemmas to consider in the design of
large-scale research in this topic area. Future evidence from large randomized control
trials (RCTs) such as the SMART Tots, MASK, and PANDA studies will hopefully paint
a clearer picture on how anesthesia affects human subjects as the brain develops.
Next, Recommendations and Implications for Advanced Nursing Practice will be
presented.
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Recommendations and Implications for Advanced Nursing Practice
The field of Certified Registered Nurse Anesthetists (CRNA) is ever growing.
These advanced practice nurses rely heavily on evidence-based research practices for
continuing education in their area. Systematic reviews that summarize the most recent
research available can be used as a tool to help advance safe practice. This information
can be useful, to not only CRNAs, but for any advanced practitioner that interacts with
the pediatric population. Knowing the patient’s anesthesia exposure history could be
beneficial. If issues with learning and memory arise this information can be used to
determine the best way to treat the individual.
CRNAs that provide anesthesia to the pediatric population can take information
from this review, and other studies, to determine the best type of anesthetic to administer.
Even though this systematic review focused on rodent subjects the results indicate
advantages and disadvantages to certain inhalation agents. For example, the study by
O’Farrell et al. (2018) found that sevoflurane caused less neurotoxicity than isoflurane.
Further Tao et al. (2016) determined that not only did isoflurane cause more
neurotoxicity than desflurane, but that it also altered learning and memory. This evidence
can better inform a provider to make a determination as to whether or not to avoid
isoflurane when administering volatile inhalation agents to gravid mothers or infants.
Further studies such as the project titled, SmartTots, which look at the long-term
effects of anesthesia and determine its safety are needed (O’Farrell., (2018). Several
studies, however, have been conducted that have focused on anesthesia exposed children
and their intelligent quotient (IQ). The Mayo Anesthesia Safety in Kids Study (MASK)
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studied the neurophysical and behavior outcomes of children after anesthesia exposure
(Warner, Zaccariello, Katusic, Schroeder, Hanson, Schulte, & Flick, 2018). The
intelligent quotient did not differ significantly. Single anesthesia exposed children had IQ
scores an average 0.5 points lower (95% CI, p= 0.70) and multiple exposed children
averaged 1.3 points lower (95% CI, p=0.32) (Warner et al., 2018). It is important to
note, however, that parents of the multiple exposure children in this study stated their
children exhibited problems related to executive function, behavior, and reading (Warner
et al., 2018). These stated secondary outcomes from the parents should be interpreted
with caution. Another study conducted by Sun, Li, Dimaggio, Byrne, Ing, Miller, &
Mcgowan (2012) called the PANDA study also reviewed IQ. This study focused on
children that received anesthesia for hernia repair before age three and compared them to
their siblings (Sun et al., 2012). The 28 children, aged 6 to11-years had no significant
difference in IQ, but this study was limited by the number of pairs evaluated (Sun et al.,
2012).
Current long-term studies involving human subject such as SmartTots may hold
the answer to how anesthesia is practiced in the future. Additional random controlled trial
studies focusing on the human pediatric patient are warranted. Future studies should be
conducted comparing anesthesia modalities such as inhalation agents versus intravenous
agents, or, versus regional. Evidence from such research may offer anesthesia providers a
way to tailor their practice for the pediatric population. In the meantime, it is important to
diligently stay educated on the newest research in this topic in order to safely administer
anesthesia to this vulnerable population.

42

References
Aker, J., Block, R., & Biddle, C. (2015). Anesthesia and the developing brain. AANA
Journal, 83(2), 139-147. Retrieved July 11, 2017.
Andropoulos, D. B. (2017). Effect of anesthesia on the developing brain: infant and fetus.
Fetal Diagnosis and Therapy, 1-11. doi:10.1159/000475928
Bennetts, P., & Pierce, J. (2010). Apoptosis: Understanding Programmed Cell Death for
the CRNA. AANA Journal,78(3), 237-245.
Brocardo, P. S., Gil-Mohapel, J., Wortman, R., Noonan, A., Mcginnis, E., Patten, A. R.,
& Christie, B. R. (2017). The Effects of Ethanol Exposure During Distinct
Periods of Brain Development on Oxidative Stress in the Adult Rat
Brain. Alcoholism: Clinical and Experimental Research, 41(1), 26–37. doi:
10.1111/acer.13266
Butterworth, J. F., Mackey, D. C., & Wasnick, J. D. (2014). Morgan & Mikhails clinical
anesthesiology. New York: McGraw-Hill Education.
Chudler, E. (2015). The Brain During Development. Retrieved from
http://faculty.washington.edu/chudler/neurok.html
Creeley, C. (2016). From Drug-Induced Developmental Neuroapoptosis to Pediatric
Anesthetic Neurotoxicity—Where Are We Now? Brain Sciences,6(3), 32.
doi:10.3390/brainsci6030032
Garcia, P., Kolesky, S., & Jenkins, A. (2010). General Anesthetic Actions on

43

GABAA Receptors. Current Neuropharmacology,8(1), 2-9.
doi:10.2174/157015910790909502
Giordano, G., & Costa, L. G. (2012). Developmental Neurotoxicity: Some Old and
New Issues. ISRN Toxicology,2012, 1-12. doi:10.5402/2012/814795
Ikonomidou, C. (1999). Blockade of NMDA Receptors and Apoptotic Neurodegeneration
in the Developing Brain. Science,283(5398), 70-74.
doi:10.1126/science.283.5398.70
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010). Animal
research: Reporting in vivo experiments: The ARRIVE guidelines. British
Journal of Pharmacology, 160(7), 1577–1579. doi: 10.1111/j.14765381.2010.00872.x
McEwen, M. & Wills, E.M. (2014). Theoretical basis for nursing. (pp. 149-152)
Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins

Moher, D., Liberati, A., Tetzlaff, J., Altman, DG. The PRISMA Group (2009).
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The
PRISMA Statement. PLoS Med 6(7): e1000097.
doi:10.1371/journal.pmed1000097

44

Neuman, B., & Fawcett, J. (2009, July). Neuman Systems Model. Retrieved
July 22, 2017, from http://neumanssystemsmodel.org/
O’Farrell, R. A., Foley, A. G., Buggy, D. J., & Gallagher, H. C. (2018). Neurotoxicity of
Inhalation Anesthetics in the Neonatal Rat Brain: Effects on Behavior and
Neurodegeneration in the Piriform Cortex. Anesthesiology Research and
Practice,2018, 1-9. doi:10.1155/2018/6376090
Parker, M. O., Evans, A. M., Brock, A. J., Combe, F. J., Teh, M., & Brennan, C. H.
(2014). Moderate alcohol exposure during early brain development increases
stimulus-response habits in adulthood. Addiction Biology,21(1), 49-60.
doi:10.1111/adb.12176
Reddy, S. (2012). Effect of general anesthetics on the developing brain. Journal of
Anaesthesiology Clinical Pharmacology, 28(1), 6-10. doi:10.4103/09709185.92426
Rothbaum, R., Aly, H., & Massaro, A. (2015). Fetal brain development: The role of
maternal nutrition, exposures, and behaviors. Journal of Pediatric
Neurology,04(01), 001-009. doi:10.1055/s-0035-1557300
Shafer, S. L., Rathmell, J. P., Flood, P., & Stoelting, R. K. (2015). Stoelting's
pharmacology and

physiology in anesthetic practice. Philadelphia, PA:

Wolters Kluwer Health.
Stiles, J., & Jernigan, T. L. (2010). The Basics of Brain Development. Neuropsychology
Review,20(4), 327-348. doi:10.1007/s11065-010-9148-4

45

Sun, L. S., Li, G., Dimaggio, C. J., Byrne, M. W., Ing, C., Miller, T. L. K., Mcgowan, F.
X. (2012). Feasibility and Pilot Study of the Pediatric Anesthesia
NeuroDevelopment Assessment (PANDA) Project. Journal of Neurosurgical
Anesthesiology, 24(4), 382–388. doi: 10.1097/ana.0b013e31826a0371
Tao, G., Xue, Q., Luo, Y., Li, G., Xia, Y., & Yu, B. (2016). Isoflurane is more
deleterious to developing brain than desflurane: the Role of the
Akt/GSK3βSignaling Pathway. BioMed Research International, 2016, 1-10.
doi:10.1155/2016/7919640
Vilsides, P., & Xie, Z. (2012). Neurotoxicity of General Anesthetics: An Update. Current
Pharmaceutical Design,18(38), 6232-6240. doi:10.2174/138161212803832344
Warner, D. O., Zaccariello, M. J., Katusic, S. K., Schroeder, D. R., Hanson, A. C.,
Schulte, P. J., Flick, R. P. (2018). Neuropsychological and Behavioral Outcomes
after Exposure of Young Children to Procedures Requiring General
Anesthesia. Anesthesiology, 129(1), 89–105. doi: 10.1097/aln.0000000000002232
Wilder, R., Flick, R., Sprung, J., Katusic, S., Barbaresi, W., Mickelson, C., . . . Warner,
D. (2009). Early Exposure to Anesthesia and Learning Disabilities in a
Population-Based Birth Cohort. Survey of Anesthesiology,53(6), 267-268.
doi:10.1097/sa.0b013e3181be865c
Wu, C., & Sun, D. (2015). GABA Receptors in Brain Development, Function, and
Injury. Metab Brain Disorders,30(2), 367-379. doi:10.1007/s11011-014-9560-1
Wu, C., Wang, J., Guo, X., & Zhang, Y. (2018). Ketamine exacerbates cortical
neuroapoptosis under hyperoxic conditions by upregulating expression of the N-

46

methyl-D-aspartate receptor subunit NR1 in the developing rat brain. BMC
Anesthesiology,18(1). doi:10.1186/s12871-018-0511-y
Young, R. (2012). Nutrient and iron deficiency: Focus on fetal brain development and
beyond. International Journal of Childbirth Education, 27(4), 65–69.
Zheng, S. Q., An, L. X., Cheng, X., & Wang, Y. J. (2013). Sevoflurane causes neuronal
apoptosis and adaptability changes of neonatal rats. Acta Anaesthesiologica
Scandinavica,57(9), 1167-1174. doi:10.1111/aas.12163

47

Appendix A
PRISMA 2009 Checklist

Section/topic

Checklist item
#

TITLE
Title

1

Identify the report as a systematic review, meta-analysis, or
both.

ABSTRACT
Provide a structured summary including, as applicable:
background; objectives; data sources; study eligibility criteria,
Structured
2 participants, and interventions; study appraisal and synthesis
summary
methods; results; limitations; conclusions and implications of
key findings; systematic review registration number.
INTRODUCTION
Describe the rationale for the review in the context of what is
Rationale
3
already known.
Provide an explicit statement of questions being addressed with
Objectives
4 reference to participants, interventions, comparisons, outcomes,
and study design (PICOS).
METHODS
Indicate if a review protocol exists, if and where it can be
Protocol and
accessed (e.g., Web address), and, if available, provide
registration
5 registration information including registration number.
Specify study characteristics (e.g., PICOS, length of follow-up)
Eligibility
and report characteristics (e.g., years considered, language,
6
criteria
publication status) used as criteria for eligibility, giving
rationale.
Describe all information sources (e.g., databases with dates of
Information
7 coverage, contact with study authors to identify additional
sources
studies) in the search and date last searched.
Present full electronic search strategy for at least one database,
Search
8
including any limits used, such that it could be repeated.
State the process for selecting studies (i.e., screening, eligibility,
Study selection 9 included in systematic review, and, if applicable, included in the
meta-analysis).
Describe method of data extraction from reports (e.g., piloted
Data collection
10 forms, independently, in duplicate) and any processes for
process
obtaining and confirming data from investigators.

Reported
on page #
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List and define all variables for which data were sought (e.g.,
11 PICOS, funding sources) and any assumptions and
simplifications made.
Describe methods used for assessing risk of bias of individual
Risk of bias in
studies (including specification of whether this was done at the
individual
12
study or outcome level), and how this information is to be used
studies
in any data synthesis.
Summary
State the principal summary measures (e.g., risk ratio,
13
measures
difference in means).
Describe the methods of handling data and combining results of
Synthesis of
14 studies, if done, including measures of consistency (e.g., I2) for
results
each meta-analysis.
Data items

PRISMA 2009 Checklist

Section/topic

Checklist item
#

Risk of bias
across studies
Additional
analyses

Specify any assessment of risk of bias that may affect the
15 cumulative evidence (e.g., publication bias, selective reporting
within studies).
Describe methods of additional analyses (e.g., sensitivity or
16 subgroup analyses, meta-regression), if done, indicating which
were pre-specified.

RESULTS
Give numbers of studies screened, assessed for eligibility, and
Study selection 17 included in the review, with reasons for exclusions at each
stage, ideally with a flow diagram.
For each study, present characteristics for which data were
Study
18 extracted (e.g., study size, PICOS, follow-up period) and
characteristics
provide the citations.
Risk of bias
Present data on risk of bias of each study and, if available, any
19
within studies
outcome level assessment (see item 12).
For all outcomes considered (benefits or harms), present, for
Results of
each study: (a) simple summary data for each intervention
20
individual studies group (b) effect estimates and confidence intervals, ideally
with a forest plot.
Synthesis of
Present results of each meta-analysis done, including
21
results
confidence intervals and measures of consistency.
Risk of bias
Present results of any assessment of risk of bias across studies
22
across studies
(see Item 15).

Reported
on page #

49

Additional
analysis
DISCUSSION
Summary of
evidence
Limitations
Conclusions

23

Give results of additional analyses, if done (e.g., sensitivity or
subgroup analyses, meta-regression [see Item 16]).

Summarize the main findings including the strength of
evidence for each main outcome; consider their relevance to
key groups (e.g., healthcare providers, users, and policy
24
makers).
Discuss limitations at study and outcome level (e.g., risk of
25 bias), and at review-level (e.g., incomplete retrieval of
identified research, reporting bias).
Provide a general interpretation of the results in the context of
26
other evidence, and implications for future research.

FUNDING
Funding

Describe sources of funding for the systematic review and
other support (e.g., supply of data); role of funders for the
27 systematic review.

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic
Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097.
doi:10.1371/journal.pmed1000097
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Appendix B
Table B-1
O’Farrell, R. A., Foley, A. G., Buggy, D. J., & Gallagher, H. C. (2018). Neurotoxicity of Inhalation Anesthetics in the Neonatal Rat Brain: Effects on Behavior
and Neurodegeneration in the Piriform Cortex. Anesthesiology Research and Practice,2018, 1-9. doi:10.1155/2018/6376090
Purpose

Study Design

The aim of this
study was to
determine if
volatile
inhalation
agents,
isoflurane and
sevoflurane,
cause damage
to the piriform
cortex of rat
pup brains as
much as
urethane.

Random control trial
using animal subjects with
a control group. All
animals were either
administered a drug or a
placebo.
The rats were
administered a single dose
of anesthetic coinciding to
their assigned groups. The
delivery method of the
anesthetic was determined
by the preferred route of
the drug. Injection for
urethane and inhalation
for isoflurane and
sevoflurane.
The control group was
administered a placebo.

Subject
Demographics
15 Day postnatal
male Wistar rats.
15-day-old rats
were used due to
the fact that rats
undergo a
prominent brain
growth spurt during
this period of time.

Methods

Measurement

The rats were divided into three groups. Urethane
n=21, isoflurane n=18, and sevoflurane n=18
respectively.
The rats were tested at 48 hours and 96 hours
where behavior parameters were noted. After
testing the rat pups were sacrificed and
histological studies were performed to determine
neurotoxic effects of the anesthetic agents
The rats were kept normothermic through
warming plates during the anesthesia delivery.
Expired end-tidal gas analyzers were used to
determine the appropriate amount of gas was
delivered to the isoflurane (2.08%) and
sevoflurane (3.4%) groups. The control group was
administered urethane and saline intravenously.
All rat groups FiO2 was maintained at 0.5.
Anesthesia was administered to each group for
four hours.

Behavior analysis of neurotoxicity:
each group was observed in an
open field environment. The
animals were studied for 5 minutes
each and observations of
vocalization, grooming habits, and
locomotion/activity were noted.
After the open-field observations
the rats were returned to their
mothers and observed for 30
minutes: maternal grooming,
vocalization, and suckling was
noted.
Histopathological studies: The rats
were euthanized using sodium
pentobarbitone. The piriform
cortex from each rat in each group
were then removed and sliced into
6 segments. Frequency of injured
and/or dying cells in each layer
were observed and counted.
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Appendix B
Table B-2
Tao. G, Xue, Q., Luo, Y., Li, G, Xia, Y., & Yu, B. (2016). Isoflurane is more deleterious to developing brain that desflurane: the told of AKT/GSK3ß
signaling pathway. BioMed Research International, 2016, 1-10. Doi:10.1155/2016/7919640
Purpose

Study Design

The aim of this
study was to
determine if the
inhalation
anesthetic
isoflurane, used
in pediatric
anesthesia, has
more
neurotoxic
effects than
desflurane.

A Random controlled trial
using three groups of mice.
The mice were divided
equally among the litters to
minimized differences
associated with different
mothers.
After being subjected to their
respective anesthetic groups
the mice were subjected to
two experiments and brain
harvesting to determine the
effects of the anesthetics,
isoflurane and desflurane, on
spatial reasoning and
memory.

Subject
Demographics
17 litters for a
total of 119 Sixday-old mice.
Both genders
utilized.
The mice were
housed at
constant
temperature with
access to food
and water. The
mice were reared
by their mother.

Methods

Measurement

The mice were divided
into three groups. An
isoflurane group,
desflurane group, and a
control group exposed
to only oxygen and
nitrogen.

At 31 days of age/post initial anesthesia dosages, all mice were
placed in the Water Maze test (MWM). Escape latency times
to evaluate spatial learning.
Platform crossing times were measured during the MWM to
determine spatial memory in each exposure group.

The mice were then
divided as equally as
possible into the
various experiments.

Fear conditioning test (FCT) was used to determine fear
conditioned memory. The mice were subjected to a sound and a
mild shock. The mice were then retested using just the sound
and freezing times
were used to determine how conditioned the mice had become
to the fear of being potentially shocked.
The Freezing times were recorded to determine fear conditioned
memory.
Western blot analysis (WBA) was used to determine
hippocampus changes in harvested mouse brains exposed to
anesthesia. The amount of
phosphorylation of proteins associated with memory.
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Appendix B
Table B-3

Wu, C., Wang, J., Guo, X., & Zhang, Y. (2018). Ketamine exacerbates cortical neuroapoptosis under hyperoxic conditions by upregulating expression of the
N-methyl-D-aspartate receptor subunit NR1 in the developing rat brain. BMC Anesthesiology,18(1). doi:10.1186/s12871-018-0511-y
Purpose

Study Design

The aim of this study
is to determine the
possible effects of
the NMDA receptor
antagonist Ketamine
and hyperoxia has on
the developing brain.
Specifically, the NR1
receptor.

Random control trial
using rat pup models.
Rats were allocated
into four separate
groups.
• Control
group
• Ketamine
group
• Hyperoxia
group
• Ketamine +
Hyperoxia
group

Subject
Demographics
Seven-day-old male
Sprague Dawley rat
pups. Average weight
of the pups was 1216 grams. The rats
were obtained by the
Peking University
Health Center Ethics
committee on Animal
Care.

Methods

Measurement

N=72
18 rats per group.
Control group: received subcutaneous saline
injections.
Ketamine group: 50 mg/kg subcutaneous
injections at room air (21%)
Hyperoxia group: saline injections plus 60%
oxygen administration.
Ketamine + Hyperoxia group: Ketamine 50
mg/kg injections plus 60% oxygen
administration.

Blood gas levels were obtained
from each group two-hours
after subcutaneous injections.

Oxygen was administered to provide a hyperoxic
state. The oxygen level was monitored
continuously. Humidity was maintained > 80%.
Excess CO2 was absorbed via soda lime.
Arterial oxygen saturation and physical
parameters were observed.

Degree of apoptosis was
measured using TUNEL assay
and polymerase chain reaction
(PCR).
Western blot analysis was used
to determine the amount of NR1 subunits were affected in
each group.
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Appendix B
Table B-4
Zheng, S. Q., An, L. X., Cheng, X., & Wang, Y. J. (2013). Sevoflurane causes neuronal apoptosis and adaptability changes of neonatal rats. Acta
Anaesthesiologica Scandinavica,57(9), 1167-1174. doi:10.1111/aas.12163

Purpose

Study Design

Subject
Demographics

Methods

Measurement

The aim of this study
was to determine if
the increase in the
concentration and
duration of
sevoflurane causes
neurodegeneration
and behavior changes
as a rat develops.

Randomized control
trial of rat pups.

Post-natal day 7
Wistar Rats
raised by the
Laboratory
Animal Center of
Academy of
Military Medical
Sciences in
Beijing, China.

Behavior and learning
were tested at weeks five,
eight, and fourteen after
sevoflurane exposure.

Brain matter harvested to determine effects of
sevoflurane on apoptosis in the cortex and hippocampus.

The rats were placed in an
acrylic box and exposed to
sevoflurane at different
concentrations and
duration.

Histopathologic analysis: N=6 perfused with
paraformaldehyde and exposed for 24 hrs. at 4 degrees
Celsius.

Group 1: “Con”
group-control
Group 2: Sevo1%-2h
exposed to 1%
sevoflurane for two
hrs.
Group 3: Sevo1%-4h
exposed to 1%
sevoflurane for four
hrs.
Group 4: Sevo2%-2h
exposed to 2%
sevoflurane for two
hrs.
Group 5: Sevo2%-4h
exposed to 2%
sevoflurane for four
hrs.

120 rats were divided into
five separate groups of
n=24.
The total gas flow was
2L/min using 100%
oxygen and sevoflurane
was monitored using the
GE Dash 4000 anesthetic
gas monitor.

Post anesthesia rats were randomized into 3 subgroups

Western Blot Analysis: Cortex and hippocampus from
n=6 rats were removed and homogenized six hours post
anesthesia. The segments were subjected to gel
electrophoresis and the bands were analyzed by the
software Gel-Pro analyzer to determine and neurological
changes.
Open-field test: Rats were placed on a table and
movements were observed for 600 seconds.
Morris Water Maze: Rats were placed in a pool of water
and seeing how long it took them to find the platform in
the center (latency). If unable to find the platform they
were guided.
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Appendix C
Table C-1
Outcome Data Collection
O’Farrell, R. A., Foley, A. G., Buggy, D. J., & Gallagher, H. C. (2018). Neurotoxicity of Inhalation Anesthetics in the Neonatal Rat Brain: Effects on Behavior
and Neurodegeneration in the Piriform Cortex. Anesthesiology Research and Practice,2018, 1-9. doi:10.1155/2018/6376090
Data Analysis

Results related to animal behavior

Results related to apoptosis

Data was entered into a
database using GraphPad
Prism v.4.0. The data was
examined for distribution
using the KolmogorovSmirnov Test.

No significant change in activity/locomotion, rearing, and suckling scores at 48 hours, but some
changes noted at 96 hours for both sevoflurane and isoflurane exposed animals.

Piriform cell counts:

Normally distributed data
was compared using
Analysis of Variance
(ANOVA).
Data was expressed as
mean +/- SEM and
P<0.05 was deemed
statistically significant.

Activity/Locomotion: increased in activity after exposure.
Sevoflurane score 11.7 at 48 hours versus 9.9 for control (p = 0.03). Score of 15.8 at 96 hours
versus control (p = 0.02).
Isoflurane score 9.38 at 48 hours versus 9.9 for control (p = 0.03). Score of 15.4 at 96 hours
versus control (p = 0.02).
Rearing: increased post exposure
Sevoflurane score 6.78 at 48 hours versus 2.60 for control. Score of 7.56 at 96 hours versus
control. (p = 0.04)
Isoflurane score 3.38 at 48 hours versus 2.60 for control. Score of 4.25 at 96 hours versus control.
(p = 0.04)
Suckling: decreased post exposure
Sevoflurane score 1.67 at 48 hours versus 3.20 for control. Score of 0.89 at 96 hours versus
control. (p = 0.04)
Isoflurane score 2.63 at 48 hours versus 3.20 for control. Score of 1.13 at 96 hours versus control.
(p = 0.04)

Apoptic cell counts increased in
urethane and isoflurane exposed
rats. Sevoflurane exposed rats
showed little difference compared to
placebo. Counts were done using a
mean ± SEM value.
Statistically significant reduction in
total piriform cell counts versus
control (sevoflurane and isoflurane
p = 0.03 and Urethane p = 0.02).
Statistically significant increase in
apoptic cells versus control for
(isoflurane p = 0.04 and Urethane
p = 0.03). However minimal to no
change in the number of dying cells
found in the sevoflurane group
versus control group.
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Appendix C
Table C-2
Outcome Data Collection
Tao, G., Xue, Q., Luo, Y., Li, G., Xia, Y., & Yu, B. (2016). Isoflurane is more deleterious to developing brain than desflurane: the role of the Akt/GSK3β
signaling pathway. BioMed Research International,2016, 1-10. doi:10.1155/2016/7919640
Data Analysis

Results related to apoptosis

Results related to behavior and memory

Lithium Pretreatment

Data from western blot
analyses, fear conditioning test,
and escape latency/platform
crossing place trials during the
water maze trials were
expressed as means.

Isoflurane, but not desflurane
decreased phosphorylation.

Isoflurane, but not desflurane impaired
long-term memory and learning.

Lithium pretreatment was found to be
neuroprotective and helped maintain
learning and memory abilities.

Decrement of Akt and GSKB
phosphorylation has been associated
with learning and memory
impairment.

Mice in the isoflurane groups
(p = 0.0001) platform crossing times
(MWM) were worse than the control
(oxygen) group (p = 0.0153) and
desflurane (p = 0.1294).

MWM used two-way ANOVA
with Bonferroni correction to
compare differences in escape
latency among groups.
T-test and one-way ANOVA
was used to analyze fear
conditioning.

Isoflurane decreased the expression
of p-AKT from 100% to 75% with a
confidence level p < 0.01, whereas
desflurane results were unchanged
from the control and remained at
100%.p > 0.05.
Expression of GSKB for Isoflurane
p<0.001 and Desflurane p> 0.05.

FCT freezing times showed by one-way
ANOVA that Isoflurane (p < 0.01) times
decreased from normal times of 50 second
to 30 seconds, whereas Desflurane (p >
0.05) showed minimum change leading to
believe Isoflurane impaired hippocampus
memory.

A two-way ANOVA test found that lithium
administered before isoflurane exposure
decreased escape latency times in mice
treated with isoflurane compared to a group
just receiving saline as a control [F =
1.741, p = 0.0332]
One-way ANOVA testing demonstrated
that lithium treatment prior to isoflurane
exposure reversed isoflurane decreased
levels of p-Akt of p < 0.05 and p-GSKB
expression P< 0.01 leading to believe that
lithium treatment offers some reversal of
isoflurane neurotoxicity.
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Table C-3
Outcome Data Collection
Wu, C., Wang, J., Guo, X., & Zhang, Y. (2018). Ketamine exacerbates cortical neuroapoptosis under hyperoxic conditions by upregulating expression of the Nmethyl-D-aspartate receptor subunit NR1 in the developing rat brain. BMC Anesthesiology,18(1). doi:10.1186/s12871-018-0511-y
Data Analysis
All values expressed as mean +/standard deviation. Differences were
analyzed by Analysis of Variance
(ANOVA) by SPSS statistical
software.
Statistical significance was defined as
p > 0.05

Results related to arterial
oxygenation saturation
Ketamine alone had no effect on
paO2.
Rat pups exposed to hyperoxia
alone had no affect to those of the
control group (p > 0.05). Control
group PaO2 89% versus 91.5% for
the Ketamine alone group.
Ketamine and hyperoxia
together increased PaO2.
PaO2 was increased to 55% from
the control group. (p > 0.01).
No changes in pH, SaO2, or PaCO2
were noted in the four groups.

Results related to neural apoptosis
Ketamine with and without
hyperoxia caused apoptosis in the
frontal cortex.
Hyperoxia alone: Rat pups
exposed to hyperoxia alone had
apoptic scores similar (around 1%)
to those of the control group (p >
0.05).
Ketamine without hyperoxia:
increased amount of apoptic cell
death (p > 0.01) around 30%.
Ketamine with hyperoxia:
increased amount of apoptic cell
death (p > 0.01) around 55%.

Results related to effect on mRNA and
NR1
Ketamine with and without hyperoxia
increases the expression of mRNA and
NR1. NR1 increase is related to increased
neurotoxicity.
Ketamine without hyperoxia: increased
amount of mRNA and NR1 subunit
expression from 0.3 unitsin the control
group versus 0.7 units in the ketamine
alone group (p > 0.01).
Ketamine with hyperoxia: increased
amount of mRNA and NR1 subunit
expression from 0.3 units in the control
group versus 1.6 units in the ketamine with
hyperoxia (p > 0.01).
No affect with the hyperoxia only group
versus the control (p > 0.05).
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Table C-4
Outcome Data Collection
Zheng, S. Q., An, L. X., Cheng, X., & Wang, Y. J. (2013). Sevoflurane causes neuronal apoptosis and adaptability changes of
neonatal rats. Acta Anaesthesiologica Scandinavica,57(9), 1167-1174. doi:10.1111/aas.12163
Data Analysis
Western Blot Analysis and
Histopathologic studies, minimal
group size of 6 determined to detect
a difference between means of 40%
with an 80% power significance
level of 0.05 (p=0.05).
Data was expressed as standard
deviation. Difference comparison
was determined using Analysis of
Variance (ANOVA).

Results related to Respiratory
Compensation under Sevoflurane
exposure
Neonatal exposure to 2%
sevoflurane causes no significant
disturbance of ventilation and
oxygen.
pH levels remained within normal
limits for compensated acidosis for
2% sevoflurane.
pH 7.34 without sevoflurane.
pH 7.37 after 2-hour sevoflurane
exposure.
pH 7.31 after 4-hour sevoflurane
exposure.

Results related to apoptosis

Results related to behavior and
memory

Exposure to sevoflurane causes a
time-dependent apoptic
neurodegeneration (p < 0.05) in
hippocampus. Higher amounts of
Capase-3 cells were detected. Rats
exposed to 2% sevo for 4 hours had
the most. Control 13 vs Sevo 4 hours
18

Exposure to sevoflurane enhances
excitability of the rats.
Rats exposed to sevo had more
movements than control group
(p < 0.05)

Exposure to sevoflurane induces
cleavage of PARP-1 in hippocampus
(p < 0.05) increase then control
group.

Exposure to sevoflurane had no
significant impairment of memory
and learning in the rats.
Control group took a 130 cm path to
the platform during the Morris water
maze versus 120 cm for Sevoflurane
exposed
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Appendix D
ARRIVE Grading Score
References
Zheng et al.
(2013)
Tao et al.
(2016)
O’ Farrell et
al. (2018)
Wu et al.
(2018)
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Methodology Key
Item

1. Title
2. Abstract
3. Background
4. Objectives
5. Ethical Statement
6. Study Design
7. Experimental Procedures
8. Experimental Animals
9. Housing and Husbandry
10. Sample Size
11. Animal Group Allocation
12. Experimental Outcomes
13. Statistical Methods
14. Baseline Data
15. Numbers Analyzed
16. Outcomes and Estimation
17. Adverse Events
18. Interpretation/ Scientific Implications
19. Generalizability/Translation
20. Funding
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Appendix E
Cross-study Analysis
Author/Year/Anesthetic Behavioral Analysis
Results

Histological Study Results

Neurodegeneration Results

O’ Farrell et al. (2018)
(Volatile Gas)

-Sevoflurane and isoflurane
enhance excitability.

-Piriform cortical cells were counted.
A significant reduction in cells were
found in isoflurane (p = 0.04) and
sevoflurane (p = 0.02) exposed
groups when compared to control
groups.

Tao et al. (2016)
(Volatile Gas)

-Isoflurane affected longterm memory and learning;
desflurane did not.
Platform crossing times with
the Morris Water Maze were
higher in isoflurane exposed
rats (80 seconds) versus (60
seconds) the control and
desflurane rat groups.

- There was decreased
phosphorylation of Akt and GSK3B
in isoflurane exposed, but not
desflurane exposed rats. Desflurane
remained at 100% levels whereas
isoflurane dropped to approximately
75% in Akt and GSKB levels.

-Sevoflurane was found to induce less neurotoxicity
than isoflurane. The number of apoptic cells in
sevoflurane exposed rats at 48 hours post exposure
were 1.75 micrometer, versus 2.25 micrometers in
isoflurane rats. At 6 hours post exposure sevofluranre
rats remained at 1 micrometer versus 2.25 in those
exposed to isoflurane (p <0.05).
-Isoflurane was found to induce more neurotoxicity
than desflurane. A reduction was found in Akt and
GSK3B enzyme levels that are used in signaling
pathways linked to brain development and learning.

Wu et al. (2018)
(Ketamine)

Zheng et al. (2013)
(Volatile Gas)

N/A

-Sevoflurane enhances
excitability. More
movements were found in
flat plane and vertical plane
with sevoflurane exposure
(p<0.05).

-Higher mRNA and NR-1 subunit
expression in those exposed to
ketamine, ketamine + hyperoxia.
-Sevoflurane exposure increases
cleavage of PARP-1 in the
hippocampus. 1.2 Beta Lactin versus
0.7 in the control group (p<0.05).

-Ketamine with, and without, hyperoxia exposure
increases neuroapoptosis. Apoptic cells of Ketamine
exposed rats increased 35% versus the control group.
Ketamine + hyperoxia exposure increased the amount
of apoptic cells to 55% above the control group.
- Exposure to sevoflurane in the neonatal rat
induces apoptic neurodegeneration.
23 Capase-3 Positive Cells (apoptic cells) versus 17 in
the control group (p<0.05).

